MENU

BBOT BridgeBio Oncology Therapeutics Inc Forecast, Technical & Fundamental Analysis

BridgeBio Oncology Therapeutics Inc, is a clinical-stage biotechnology company that aims to transform the lives of patients with cancers driven by RAS and PI3Ka, the two frequently mutated oncogenes... Show more

BBOT
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
View a ticker or compare two or three
BBOT
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I. Advisor
published Earnings

BBOT is expected to report earnings to fall 99.92% to -56 cents per share on November 18

BridgeBio Oncology Therapeutics Inc BBOT Stock Earnings Reports
Q3'26
Est.
$-0.57
Q2'26
Missed
by $704.68
Q1'26
Missed
by $0.06
Q4'25
Missed
by $0.07
The last earnings report on August 11 showed earnings per share of -70520 cents, missing the estimate of -51 cents. With 196.07K shares outstanding, the current market capitalization sits at 305.46M.
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Industry
N/A
Address
256 East Grand Avenue
Phone
+1 650 405-4770
Employees
92
Web
https://www.bridgebio.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
SMOM29.110.20
+0.70%
Symmetry Panoramic Sector Momentum ETF (SMOM)
HELS23.830.12
+0.52%
Hedgeye 130/30 Equity ETF (HELS)
IWF125.730.47
+0.38%
iShares Russell 1000 Growth ETF (IWF)
SHYL42.74-0.21
-0.49%
Xtrackers Short Duration High Yield Bond ETF (SHYL)
CGW61.90-0.44
-0.71%
Invesco S&P Global Water Index ETF (CGW)

BBOT and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, BBOT has been loosely correlated with NKTX. These tickers have moved in lockstep 35% of the time. This A.I.-generated data suggests there is some statistical probability that if BBOT jumps, then NKTX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BBOT
1D Price
Change %
BBOT100%
-3.90%
NKTX - BBOT
35%
Loosely correlated
-2.29%
IMNM - BBOT
34%
Loosely correlated
-2.88%
MIST - BBOT
33%
Loosely correlated
-5.78%
PRME - BBOT
33%
Poorly correlated
-2.13%
EDIT - BBOT
32%
Poorly correlated
-1.95%
More
BridgeBio Oncology Therapeutics (BBOT) stock Forecast, Price Targets and Analysts Predictions - Tickeron.com